Richard Festenstein

3.7k total citations
37 papers, 2.7k citations indexed

About

Richard Festenstein is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Richard Festenstein has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 9 papers in Genetics. Recurrent topics in Richard Festenstein's work include Genomics and Chromatin Dynamics (15 papers), Genetic Neurodegenerative Diseases (11 papers) and Epigenetics and DNA Methylation (7 papers). Richard Festenstein is often cited by papers focused on Genomics and Chromatin Dynamics (15 papers), Genetic Neurodegenerative Diseases (11 papers) and Epigenetics and DNA Methylation (7 papers). Richard Festenstein collaborates with scholars based in United Kingdom, United States and Germany. Richard Festenstein's co-authors include Dimitris Kioussis, Niall Dillon, Patrick J. Wijchers, Alexander Saveliev, Mauro Tolaini, Alain Verreault, Margaret Fox, Zoë Webster, C. M. Everett and Cihangir Yandım and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

Richard Festenstein

36 papers receiving 2.7k citations

Peers

Countries citing papers authored by Richard Festenstein

Since Specialization

Citations

This map shows the geographic impact of Richard Festenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Festenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Festenstein more than expected).

Fields of papers citing papers by Richard Festenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Festenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Festenstein. The network helps show where Richard Festenstein may publish in the future.

Co-authorship network of co-authors of Richard Festenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Festenstein. A scholar is included among the top collaborators of Richard Festenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Festenstein. Richard Festenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	A wearable motion capture suit and machine learning predict disease progression in Friedreich’s ataxia	Nature Medicine	Suran Nethisinghe, Valeria Ricotti et al.	36
2	Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy	Nature Medicine	Valeria Ricotti, Richard Festenstein et al.	42
3	Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer’s disease mouse model	Molecular Psychiatry	Roy Chun-Laam Ng, Min Jian et al.	66
4	Identification of a novel distal regulatory element of the humanNeuroglobingene by the chromosome conformation capture approach	Nucleic Acids Research	Wei Zhang, Pui Pik Law et al.	21
5	Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study	The Lancet	Vincenzo Libri, Cihangir Yandım et al.	107
6	Transcription Elongation and Tissue-Specific Somatic CAG Instability	PLoS Genetics	Agnieszka Styś, Yvon Trottier et al.	43
7	Epigenetic regulation of autosomal gene expression by sex chromosomes	Trends in Genetics	Patrick J. Wijchers, Richard Festenstein	124
8	H3 Lysine 4 Is Acetylated at Active Gene Promoters and Is Regulated by H3 Lysine 4 Methylation	PLoS Genetics	Benoît Guillemette, Paul Drogaris et al.	153
9	The molecular basis for stability of heterochromatin-mediated silencing in mammals	Epigenetics & Chromatin	Kyoko Hiragami-Hamada, Sheila Q. Xie et al.	17
10	The in vivoexpression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus	Arthritis Research & Therapy	Anthony P. Manderson, Francesco Carlucci et al.	18
11	Heterochromatin protein 1: a pervasive controlling influence	Cellular and Molecular Life Sciences	Richard Festenstein et al.	112
12	DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing	Nature	Alexander Saveliev, C. M. Everett et al.	205
13	Heritable gene silencing in lymphocytes delays chromatid resolution without affecting the timing of DNA replication	Nature Cell Biology	Véronique Azuara, Karen Brown et al.	85
14	Evidence for Distinct CD4 Silencer Functions at Different Stages of Thymocyte Differentiation	Molecular Cell	Ichiro Taniuchi, Mary Jean Sunshine et al.	105
15	Unravelling heterochromatin: competition between positive and negative factors regulates accessibility	Trends in Genetics	Niall Dillon, Richard Festenstein	193
16	Locus control regions and epigenetic chromatin modifiers	Current Opinion in Genetics & Development	Richard Festenstein, Dimitris Kioussis	65
17	Human HMG box transcription factor HBP1: a role in hCD2 LCR function	The EMBO Journal	Belaïd Sekkali, George Skavdis et al.	51
18	Heterochromatin protein 1 modifies mammalian PEV in a dose- and chromosomal-context- dependent manner	Nature Genetics	Richard Festenstein, Soheila Sharghi-Namini et al.	101
19	Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals	Current Opinion in Genetics & Development	Dimitris Kioussis, Richard Festenstein	128
20	Random activation of a transgene under the control of a hybrid hCD2 locus control region/Ig enhancer regulatory element.	The EMBO Journal	James I. Elliott, Richard Festenstein et al.	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact